Morphine deprivation increases self-administration of the fast- and short-acting μ-opioid receptor agonist remifentanil in the rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 326, Issue 3, 2008, Pages 920-929

  Cooper, Ziva D ^a,b,d   Yen, Nhu Thi Truong ^c   Shi, Yong Gong ^c   Woods, James H ^b  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; MORPHINE; MU OPIATE RECEPTOR AGONIST; REMIFENTANIL; SHORT ACTING DRUG; DELAYED RELEASE FORMULATION; MU OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; PIPERIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SELF ADMINISTRATION; EXPLORATORY BEHAVIOR; HYPERALGESIA; INSTRUMENTAL CONDITIONING; MALE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT; REINFORCEMENT; WEIGHT CHANGE; WITHDRAWAL SYNDROME; WRITHING TEST; ADDICTION; ADMINISTRATION AND DOSAGE; AGONISTS; ANIMAL; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; PHYSIOLOGY; PSYCHOLOGY; SPRAGUE DAWLEY RAT;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ADDICTIVE; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; MALE; MORPHINE; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SELF ADMINISTRATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 53849110907     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.139196     Document Type: Article

References (59)

1. Ahmed SH and Koob GF (1998) Transition from moderate to excessive drug intake: change in hedonic set point. Science 282:298-300.
2. Ahmed SH, Walker JR, and Koob GF (2000) Persistent increase in the motivation to take heroin in rats with a history of drug escalation. Neuropsychopharmacology 22:413-421.
3. Baird TJ, Deng SX, Landry DW, Winger G, and Woods JH (2000) Natural and artificial enzymes against cocaine: I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats. J Pharmacol Exp Ther 295:1127-1134.
4. Bhargava HN (1977) Rapid induction and quantitation of morphine dependence in the rat by pellet implantation. Psychopharmacology 52:55-62.
5. Bläsig J, Herz A, Reinhold K, and Zieglgänsberger S (1973) Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats. Psychopharmacologia 33:19-38.
6. Bruins Slot LA and Colpaert FC (1999a) Recall rendered dependent on an opiate state. Behav Neurosci 113:337-344.
7. Bruins Slot LA and Colpaert FC (1999b) Opiate states of memory: receptor mechanisms. J Neurosci 19:10520-10529.
8. Bruins Slot LA and Colpaert FC (1999c) Experimental realization of a signal transduction algorithm. J Theor Biol 200:39-48.
9. Bruins Slot LA, Pauwels PJ, and Colpaert FC (2002) Sign-reversal during persistent activation in mu-opioid signal transduction. J Theor Biol 215:169-182.
10. Chen SA, O'Dell LE, Hoefer ME, Greenwell TN, Zorrilla EP, and Koob GF (2006) Unlimited access to heroin self-administration: independent motivational markers of opiate dependence. Neuropsychopharmacology 31:2692-2707.
11. Colpaert FC (1996) System theory of pain and of opiate analgesia: no tolerance to opiates. Pharmacol Rev 48:355-402.
12. Colpaert FC, Deseure K, Stinus L, and Adriaensen H (2006) High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning. J Pharmacol Exp Ther 316:892-899.
13. Coombs WT, Algina J, and Oltman DO (1996) Univariate and multivariate omnibus hypothesis tests selected to control type I error rates when population variances are not necessarily equal. Rev Educ Res 66:137-179.
14. Dai S, Corrigall WA, Coen KM, and Kalant H (1989) Heroin self-administration by rats: influence of dose and physical dependence. Pharmacol Biochem Behav 32:1009-1015.
15. Dole VP (1972) Narcotic addiction, physical dependence and relapse. N Engl J Med 286:988-992.
16. Espejo EF, Serrano MI, Caillé S, and Stinus L (2001) Behavioral expression of opiate withdrawal is altered after prefrontocortical dopamine depletion in rats: monoaminergic correlates. Neuropsychopharmacology 25:204-212.
17. Fendt M and Mucha RF (2001) Anxiogenic-like effects of opiate withdrawal seen in the fear-potentiated startle test, an interdisciplinary probe for drug-related motivational states. Psychopharmacology 155:242-250.
18. Gellert VF and Holtzman SG (1978) Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions. J Pharmacol Exp Ther 205:536-546.
19. Giamberardino MA, Valente R, de Bigontina P, and Vecchiet L (1995) Artificial ureteral calculosis in rats: behavioural characterization of visceral pain episodes and their relationship with referred lumbar muscle hyperalgesia. Pain 61:459-469.
20. Gintzler AR and Chakrabarti S (2006) Post-opioid receptor adaptations to chronic morphine; altered functionality and associations of signaling molecules. Life Sci 79:717-722.
21. Haidar SH, Moreton JE, Liang Z, Hoke JF, Muir KT, and Eddington ND (1997) Evaluating a possible pharmacokinetic interaction between remifentanil and esmolol in the rat. J Pharm Sci 86:1278-1282.
22. Harris AC, Hanes SL, and Gewirtz JC (2004) Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures. Psychopharmacology 176:266-273.
23. Houshyar H, Cooper ZD, and Woods JH (2001) Paradoxical effects of chronic morphine treatment on the temperature and pituitary-adrenal responses to acute restraint stress: a chronic stress paradigm. J Neuroendocrinol 13:862-874.
24. Houshyar H, Gomez F, Manalo S, Bhargava A, and Dallman MF (2003) Intermittent morphine administration induces dependence and is a chronic stressor in rats. Neuropsychopharmacology 28:1960-1972.
25. Hutcheson DM, Everitt BJ, Robbins TW, and Dickinson A (2001) The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nat Neurosci 4:943-947.
26. Kayan S, Woods LA, and Mitchell CL (1971) Morphine-induced hyperalgesia in rats tested on the hot plate. J Pharmacol Exp Ther 177:509-513.
27. Kenny PJ, Chen SA, Kitamura O, Markou A, and Koob GF (2006) Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J Neurosci 26:5894-5900.
28. Kitamura O, Wee S, Specio SE, Koob GF, and Pulvirenti L (2006) Escalation of methamphetamine self-administration in rats: a dose-effect function. Psychopharmacology 186:48-53.
29. Ko MC, Terner J, Hursh S, Woods JH, and Winger G (2002) Relative reinforcing effects of three opioids with different durations of action. J Pharmacol Exp Ther 301:698-704.
30. Koob GF and Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97-129.
31. Langerman L, Piscoun B, Bansinath M, Shemesh Y, Turndorf H, and Grant GJ (2001) Quantifiable dose-dependent withdrawal after morphine discontinuation in a rat model. Pharmacol Biochem Behav 68:1- 6.
32. Mello NK and Mendelson JH (1985) Behavioral pharmacology of buprenorphine. Drug Alcohol Depend 14:283-303.
33. Morgan MM, Fossum EN, Stalding BM, and King MM (2006) Morphine antinociceptive potency on chemical, mechanical, and thermal nociceptive tests in the rat. J Pain 7:358-366.
34. Mullis KB, Perry DC, Finn AM, Stafford B, and Sadée W (1979) Morphine persistence in rat brain and serum after single doses. J Pharmacol Exp Ther 208:228-231.
35. Naruse T and Asami T (1987) Intravenous self-administration of diazepam in rats. Eur J Pharmacol 135:365-373.
36. Negus SS and Mello NK (2002) Effects of mu-opioid agonists on cocaine- and food-maintained responding and cocaine discrimination in rhesus monkeys: role of mu-agonist efficacy. J Pharmacol Exp Ther 300:1111-1121.
37. Negus SS (2006) Choice between heroin and food in control and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone. J Pharmacol Exp Ther 317:711-723.
38. Nichols JR (1968) Morphine as a reinforcing agent: laboratory studies of its capacity to change behavior. Res Publ Assoc Res Nerv Ment Dis 46:299-310.
39. Panlilio LV, Katz JL, Pickens RW, and Schindler CW (2003) Variability of drug self-administration in rats. Psychopharmacology 167:9-19.
40. Panlilio LV and Schindler CW (2000) Self-administration of remifentanil, an ultra-short acting opioid, under continuous and progressive-ratio schedules of reinforcement in rats. Psychopharmacology 150:61-66.
41. Piazza PV, Deroche-Gamonent V, Rouge-Pont F, and Le Moal M (2000) Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction. J Neurosci 20:4226-4232.
42. Schulteis G, Yackey M, Risbrough V, and Koob GF (1998) Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plusmaze. Pharmacol Biochem Behav 60:727-731.
43. Seiden LS and Dykstra LA (1977) Drugs as reinforcers, in Psychopharmacology: A Biochemical and Behavioral Approach, pp 359-396, Van Nostrand Reinhold Company, New York.
44. Sim-Selley LJ, Selley DE, Vogt LJ, Childers SR, and Martin TJ (2000) Chronic heroin self-administration desensitizes mu opioid receptor-activated G-proteins in specific regions of rat brain. J Neurosci 20:4555-4562.
45. Solomon RL and Corbit JD (1974) An opponent-process theory of motivation: I. Temporal dynamics of affect. Psychol Rev 81:119-145.
46. Spragg SD (1940) Morphine addiction in chimpanzees. Comparative Psychology Monographs 15:1-132.
47. Stevenson GW, Folk JE, Linsenmayer DC, Rice KC, and Negus SS (2003) Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception. J Pharmacol Exp Ther 307:1054-1064.
48. Thompson T and Schuster CR (1964) Morphine self-administration, food-reinforced, and avoidance behaviors in rhesus monkeys. Psychopharmacologia 5:87-94.
49. Tilson HA, Rech RH, and Stolman S (1973) Hyperalgesia during withdrawal as a means of measuring the degree of dependence in morphine dependent rats. Psychopharmacologia 28:287-300.
50. Viganò D, Rubino T, Di Chiara G, Ascari I, Massi P, and Parolaro D (2003) Mu opioid receptor signaling in morphine sensitization. Neuroscience 117:921-929.
51. Weeks JR and Collins RJ (1964) Factors affecting voluntary morphine intake in self-maintained addicted rats. Psychopharmacologia 6:267-279.
52. Winger G, Skjoldager P, and Woods JH (1992) Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. J Pharmacol Exp Ther 261:311-317.
53. Winger G and Woods JH (2001) The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys. Drug Alcohol Depend 62:181-189.
54. Winger G, Galuska CM, Hursh SR, and Woods JH (2006) Relative reinforcing effects of cocaine, remifentanil, and their combination in rhesus monkeys. J Pharmacol Exp Ther 318:223-229.
55. Woods JH, Downs DA and Villarreal JH (1973) Changes in operant behavior during deprivation- and antagonist-induced withdrawal states, in Psychic Dependence (Hoffmeister F and Goldberg L eds) pp 114-121, Springer-Verlag, New York.
56. Woods JH and Schuster CR (1971) Opiates as reinforcing stimuli, in Stimulus Properties of Drugs (Thompson t and Pickens RW eds) pp 163-175, Appleton-Century-Crofts, New York.
57. Woods JH and Winger GD (2002) Observing responses maintained by stimuli associated with cocaine or remifentanil reinforcement in rhesus monkeys. Psychopharmacology 163:345-351.
58. Young AM (1986) Effects of acute morphine pretreatment on the rate-decreasing and antagonist activity of naloxone. Psychopharmacology 88:201-208.
59. Zernig G, Wakonigg G, Madlung E, Haring C, and Saria A (2004) Do vertical shifts in dose-response rate-relationships in operant conditioning procedures indicate "sensitization" to "drug wanting"? Psychopharmacology 171:349-351.